ScreenerHero

PER Percheron Therapeutics Limited

ASX · AU · Healthcare · Drug Manufacturers - General · percherontx.com
—Mkt Cap: —P/E: —

Percheron Therapeutics Limited engages in the research and development of antisense pharmaceuticals for cancer and rare diseases in Australia. Its products pipeline includes HMBD-002, a recombinant humanised monoclonal I…

Industry Peers

Drug Manufacturers - General
Screen all
LLY
Eli Lilly and Company
$1.12TUSDP/E 40.5
JNJ
Johnson & Johnson
$610.38BUSDP/E 28.7
ABBV
AbbVie Inc.
$500.80BUSDP/E 80.1
RO
Roche Holding AG
$370.64BUSDP/E 25.2
ROP
Roche Holding AG
$364.40BUSDP/E 24.8
MRK
Merck & Co., Inc.
$358.21BUSDP/E 115.2
ROG
Roche Holding AG
$340.19BUSDP/E 22.7
NOVN
Novartis AG
$288.24BUSDP/E 24.0
NVS
Novartis AG
$285.83BUSDP/E 22.0
AZN
AstraZeneca PLC
$260.71BUSDP/E 25.2
AZN
AstraZeneca PLC
$260.59BUSDP/E 26.7
AZN
AstraZeneca PLC
$258.50BUSDP/E 23.9
AMGN
Amgen Inc.
$234.65BUSDP/E 26.1
AZN
AstraZeneca PLC
$260.87BUSDP/E 25.4
GILD
Gilead Sciences, Inc.
$195.13BUSD
NOVO-B
Novo Nordisk A/S
$174.33BUSDP/E 10.1
NVO
Novo Nordisk A/S
$173.08BUSDP/E 9.6
PFE
Pfizer Inc.
$167.80BUSDP/E 38.7
BMY
Bristol-Myers Squibb Company
$123.73BUSDP/E 12.8
GSK
GSK plc
$98.21BUSDP/E 14.9

Key Statistics

Company
Market Cap—
Enterprise Value1.43M USD
Revenue (TTM)583.00K USD
Gross Profit459.04K USD
Net Income (TTM)-3.31M USD
Revenue/Share0.0010 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryDrug Manufacturers - General
ISINAU0000317281
Valuation
P/E (Trailing)—
P/E (Forward)-0.85
PEG—
EV/EBITDA-0.45
EV/Revenue2.45
P/S9.40
P/B0.80
EPS (TTM)0.00
EPS (Forward)-0.00
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin78.74%
Oper. Margin-222.63%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-63.63%
ROA-58.27%
Growth
Revenue Growth-54.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.43M USD
CapEx (TTM)2.13M USD
FCF Margin-741.22%
FCF Yield—
Net Debt-2.78M USD
Net Debt/EBITDA0.88
Balance Sheet
Debt/Equity0.00
Current Ratio7.64
Quick Ratio6.95
Book Value/Sh0.0050 AUD
Cash/Share0.0030 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateNov 6, 2013
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.98B
Float1.17B
Insiders25.56%
Institutions0.00%
Technical
SMA 500.0045 AUD
SMA 2000.0051 AUD
Beta1.13
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)1.22M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—